[NKTR] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[NKTR] Nektar Therapeutics
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 10.34%
YoY- 22.37%
Quarter Report
NKTR's Result
NKTR's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 23,489 21,639 23,885 24,144 20,499 21,594 22,023 4.39%
PBT -52,317 -36,837 -42,108 -45,898 -51,169 -137,081 -56,544 -5.05%
Tax 46 -35 -29 -61 -47 -63 3,144 -94.03%
NP -52,363 -36,802 -42,079 -45,837 -51,122 -137,018 -59,688 -8.36%
Tax Rate - - - - - - - -
Total Cost 75,852 58,441 65,964 69,981 71,621 158,612 81,711 -4.84%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -222.93 -170.07 -176.17 -189.85 -249.39 -634.52 -271.03 -12.22%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.25 -0.19 -0.22 -0.24 -0.27 -0.73 -0.32 -15.18%
EPS Diluted -0.25 -0.19 -0.22 -0.24 -0.27 -0.73 -0.32 -15.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.